PANC
Healthcare BiotechnologyPanacos Pharmaceuticals, Inc.
$0.00
-0.00 -0.00% today
Price History
Not enough data
Key Stats
Market Cap
321,840.992
Avg Volume
0
52W High
$0.00
52W Low
$0.00
Div. Yield
0.0%
Valuation
P/B Ratio
0.00
P/S Ratio
3.25
EV/EBITDA
0.26
EV/Revenue
-87.70
Margins
Gross Margin 100.0%
Operating Margin (31545.8%)
Net Margin 0.0%
EBITDA Margin 0.0%
Growth & Returns
Revenue Growth (YoY)
(20.0%)
Return on Equity
(168.8%)
Return on Assets
(52.6%)
Liquidity & Leverage
Current Ratio
2.15
Quick Ratio
2.11
Debt / Equity
3.45
Total Cash
26.89M
Total Debt
18.21M
About
Panacos Pharmaceuticals, Inc., a development stage biotechnology company, engages in the discovery and development of small-molecule oral drugs designed to treat human immunodeficiency virus (HIV) and other human viral diseases. The company's discovery technologies focus on novel targets in the virus life cycle, including virus maturation and virus fusion. Its product pipeline includes second- and third-generation programs in HIV maturation inhibition. The company was founded in 1999 and is headquartered in Watertown, Massachusetts.